CBLB and renal cell carcinoma: They demonstrated that the CD70/CISH/CBLB triple-knockout CD70-CAR-NK cells enhanced anti-tumour activity against renal cell carcinoma (RCC) solid tumour cell lines and provided improved resistance to TGFβ-mediated inhibition, therefore not only avoiding immune escape but also immune inhibition with their novel approach [213].